Trial Profile
Evaluation of effect of Glubes combination tablet on the HbA1c levels and vascular endothelial function
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 16 Dec 2019
Price :
$35
*
At a glance
- Drugs Mitiglinide/voglibose (Primary) ; Glimepiride
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms EGEF
- 13 Dec 2019 Status changed from recruiting to discontinued.
- 05 Jul 2012 New trial record